Short communication clonidine pharmacokinetics in pregnancy

Drug Metabolism and Disposition

Volumn 37, Issue 4, 2009, Pages 702-705

  Buchanan, M L ^a   Easterling, T R ^b   Carr, D B ^b   Shen, D D ^a,c   Risler, L J ^c   Nelson, W L ^a   Mattison, D R ^d   Hebert, M F ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; CREATININE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DELIVERY; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; GLOMERULUS FILTRATION; HUMAN; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL PLASMA; PHARMACOKINETICS; PREGNANCY; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD; URINE PH; VENOUS BLOOD; AREA UNDER THE CURVE; BLOOD; HALF LIFE TIME; HYPERTENSION; PREGNANCY COMPLICATION;

ADRENERGIC ALPHA-AGONISTS; ADULT; AREA UNDER CURVE; CLONIDINE; FEMALE; HALF-LIFE; HUMANS; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 63849125212     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.024984     Document Type: Article

References (17)

1. Arndts D, Stähle H, and Struck CJ (1979) A newly developed precise and sensitive radioimmunoassay for clonidine. Arzneimittelforschung 29:532-538.
2. Arndts D (1983) New aspects of clinical pharmacology of clonidine. Chest 83:397-400.
3. Boutroy MJ, Gisonna CR, and Legagneur M (1988) Clonidine: placental transfer and neonatal adaptation. Early Hum Dev 17:275-286.
4. Cunningham FE, Baughman VL, Peters J, and Laurito CE (1994) Comparative pharmacokinetics of oral versus sublingual clonidine. J Clin Anesth 6:430-433.
5. Darda S, Förster HJ, and Sthle H (1978) Metabolic degradation of clonidine. Arzneimittelforschung 28:255-259.
6. Davies DS, Wing AM, Reid JL, Neill DM, Tippett P, and Dollery CT (1977) Pharmacokinetics and concentration-effect relationships of intravenous and oral clonidine. Clin Pharmacol Ther 21:593-601.
7. Davison JM and Noble MC (1981) Serial changes in 24 h creatinine clearance during normal menstrual cycles and the first trimester. Br J Obstet Gynaecol 88:10-17.
8. Dollery SC (1991) Clonidine (hydrochloride), in Therapeutic Drugs (Dollery SC, ed) pp C305-C311, Churchill Livingstone, New York.
9. Fujimura A, Ebihara A, Ohashi K, Shiga T, Kumagai Y, Nakashima H, and Kotegawa T (1994) Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects. J Clin Pharmacol 34:260-265.
10. Hartikainen-Sorri AL, Heikkinen JE, and Koivisto M (1987) Pharmacokinetics of clonidine during pregnancy and nursing. Obstet Gynecol 69:598 -600.
11. Hebert MF, Easterling TR, Kirby B, Carr D, Buchanan M, Rutherford T, Thummel K, Fishbein D, and Unadkat J (2008) Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 84:248-253.
12. Hulter HN, Licht JH, Ilnicki LP, and Singh S (1979) Clinical efficacy and pharmacokinetics of clonidine in hemodialysis and renal insufficiency. J Lab Clin Med 94:223-231.
13. Kobinger W (1978) Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81:40-100.
14. Lowenthal DT (1980) Pharmacokinetics of clonidine. J Cardiovasc Pharmacol 2:S29-S37.
15. Porchet HC, Piletta P, and Dayer P (1992) Pharmacokinetic-pharmacodynamic modeling of the effects of clonidine on pain threshold, blood pressure, and salivary flow. Eur J Clin Pharmacol 42:655-661.
16. Tracy TS, Venkataramanan R, Glover DD, and Caritis SN (2005) for the National Institute for Child Health and Human Development Network of Maternal-Fetal Medicine Units. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 192:633-639.
17. Yerby MS, Friel PN, McCormick K, Koerner M, Van Allen M, Leavitt AM, Sells CJ, and Yerby JA (1990) Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Res 5:223-228.